RenovoRx, PRISM-TAMP, TAMP, Trans-Arterial Micro-Perfusion, RenovoCath, Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, PDAC, Borderline Resectable Pancreatic Cancer,

MOUNTAIN VIEW, Calif. — October 7, 2026 RenovoRx announced that the first patient has been enrolled in PRISM-TAMP, an...